908 Devices Inc.

Equities

MASS

US65443P1021

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:00:00 2024-04-15 pm EDT 5-day change 1st Jan Change
5.79 USD -4.61% Intraday chart for 908 Devices Inc. -12.14% -48.40%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
908 Devices Inc. Trace Chemical Identification Technology Adopted by European Agencies CI
Transcript : 908 Devices Inc., Q4 2023 Earnings Call, Mar 05, 2024
908 Devices Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
908 Devices Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Earnings Flash (MASS) 908 DEVICES Reports Q4 Revenue $14.4M MT
908 Devices Inc. Provides Earnings Guidance for the Full Year 2024 CI
North American Morning Briefing : S&P 500 Futures -2- DJ
908 Devices Stock Falls After CFO Reports Share Sale MT
908 Devices Inc. Announces MX908 Integration Capabilities CI
908 Devices Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Transcript : 908 Devices Inc., Q3 2023 Earnings Call, Nov 07, 2023
Earnings Flash (MASS) 908 DEVICES Posts Q3 Revenue $14.3M MT
908 Devices Inc. Provides Earnings Guidance for the Full Year 2023 CI
908 Devices Inc. and Terumo Blood and Cell Technologies Collaborate to Add On-Line Analytics to Quantum Flex Cell Expansion System CI
908 Devices Gets $10.4 Million Order From US Defense Forces MT
908 Devices Inc. Receives $10.4 Million Order from the United States Air Force for Its Handheld MX908 Device CI
908 Devices Inc. Enters Initial Production Phase of US Department of Defense Aerosol and Vapor Chemical Agent Detector Program CI
908 Devices Launches Maverick for Real-Time In-Line Monitoring of Multiple Bioprocess Parameters CI
908 Devices Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Transcript : 908 Devices Inc., Q2 2023 Earnings Call, Aug 08, 2023
908 Devices Inc. Enters into Default Waiver and First Amendment to Loan and Security Agreement with Silicon Valley Bank CI
Earnings Flash (MASS) 908 DEVICES Posts Q2 Revenue $12.1M MT
908 Devices Inc. Updates Revenue Guidance for the Year 2023 CI
908 Devices Inc. Partners with Tennessee State and Local Agencies in the Fight Against Drug Trafficking Through New Pilot Program CI
908 Devices Inc Announces the Launch of MX908 Beacon CI
Chart 908 Devices Inc.
More charts
908 Devices Inc. offers a suite of purpose-built handheld and desktop mass spectrometry (Mass Spec) devices for the point of need chemical and biochemical analysis. The Company's Mass Spec devices are used at the point of need to interrogate unknown and invisible materials and provide answers to address problems in life sciences research, bioprocessing, industrial biotechnology, forensics and adjacent markets. Its products include MX908, Rebel, ZipChip, Maven and Maverick. MX908 is a handheld, battery-powered, Mass Spec device designed for the analysis of solid, liquid, vapor and aerosol materials of unknown identity. MX908 is a multi-purpose device utilized by a spectrum of user segments for a variety of forensic field applications, including chemical, explosive, priority drug and hazardous materials operations, detecting materials at the trace level. The Rebel is a small desktop analyzer providing real-time information on the extracellular environment in bioprocesses.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
5.79 USD
Average target price
15.33 USD
Spread / Average Target
+164.82%
Consensus
  1. Stock Market
  2. Equities
  3. MASS Stock
  4. News 908 Devices Inc.
  5. 908 Devices : Earnings Flash (MASS) 908 DEVICES Posts Q2 Revenue $8.3M, vs. Street Est of $7.15M